임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

21건 표시

1상모집 예정· Healthy Subjects
Bioequivalence Study Between YHP2508C and YHR2603 in Healthy Subjects
리드: 유한양행
상세 →NCT07584304
3상모집 예정· Hypertension
A Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential Hypertension
리드: 한미약품
상세 →NCT07660796
해당없음모집 예정· Chronic Coronary Syndrome
Comparison of the Incidence of Major Cardiovascular Events Between the Combination of Percutaneous Intervention and Optimal Drug Therapy and the Optimal Drug Therapy Alone in Patients With Chronic Coronary Syndrome
협력: 종근당
상세 →NCT07577518
3상모집 예정· Varicella (Chickenpox)
SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years
리드: SK바이오사이언스
상세 →NCT07415252
1상모집 예정· Ovarian Cancer
Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
리드: 종근당
상세 →NCT07532148
3상모집 예정· T2DM (Type 2 Diabetes Mellitus)
To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes Mellitus
리드: 대웅제약
상세 →NCT07619833
단계 미표기모집 예정· Dyslipidemia
Efficacy and Safety of Baroezet Tablet in Korean Patients With Dyslipidemia: A Prospective Observational Study
리드: 대웅제약
상세 →NCT07515560
단계 미표기모집 예정· Peptic Ulcer
Fexuclue for Prevention of NSAIDs-Induced Peptic Ulcer in Real-World Practice
리드: 대웅제약
상세 →NCT07558707
해당없음모집 예정· Respiratory Infection Virus
Noseguard for Prevention of Respiratory Infections in Real-World Use
리드: 대웅제약
상세 →NCT07516977
4상모집 예정· NSAID (Non-Steroidal Anti-Inflammatory Drug)
Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer
리드: 대웅제약
상세 →NCT07533266
4상모집 예정· Diabete Type 2
Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus Patients
리드: 종근당
상세 →NCT07365358
1상모집 예정· Benign Prostate Hypertrophy(BPH)
A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846
리드: 종근당
상세 →NCT07404735
1상모집 예정· Healthy
A Study to Evaluate the Pharmacokinetics and Safety Between HIP2503 and HCP1306 in Healthy Volunteers
리드: 한미약품
상세 →NCT07297693
단계 미표기모집 예정· Psoriasis
Phase 4 Multicenter, Open-label Study on Efficacy and Safety of Apremilast in Moderate-to-severe Psoriasis
리드: 대웅제약
상세 →NCT07190391
4상모집 예정· Heart Transplant
Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea
리드: 종근당
상세 →NCT06942156
3상모집 예정· Glabellar Lines
Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines
리드: 대웅제약
상세 →NCT07013279
3상모집 예정· Androgenetic Alopecia
A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia
리드: 종근당
상세 →NCT06916793
1상모집 예정· Healthy
Phase 1 Study of Drug-Drug Interactions Between DWP16001, DWC202407, and DWC202408 in Healthy Adults
리드: 대웅제약
상세 →NCT06644404
1상모집 예정· Healthy Volunteers
Bioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315
리드: 대웅제약
상세 →NCT06592495
3상모집 예정· Type 2 Diabetic Nephropathy
Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients
리드: 대웅제약
상세 →NCT06606093
1상모집 예정· Type 2 Diabetes Mellitus
To Evaluate the Food Effect on Pharmacokinetic Profiles and Safety in Healthy Volunteers
리드: 종근당
상세 →NCT06492655

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.